The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Increase Is Anticipated For The Single-Cell Genome Sequencing Market Over The 2026–2030 Period?
The single-cell genome sequencing market size has experienced swift growth in recent years. Its projected expansion indicates an increase from $2.83 billion in 2025 to $3.26 billion in 2026, at a compound annual growth rate (CAGR) of 15.2%. Historically, this growth can be attributed to factors like early adoption in research, existing limited sequencing resolution, the high cost of single-cell analysis, a growing demand for personalized medicine research, and increasing collaborations in genomics.
The single-cell genome sequencing market size is anticipated to expand rapidly over the next few years. It is projected to reach $5.84 billion by 2030, advancing at a compound annual growth rate (CAGR) of 15.7%. This expansion during the forecast period is fueled by the emergence of high-throughput single-cell platforms, increased application in clinical diagnostics, the incorporation of AI and bioinformatics, its uptake in multi-omics studies, and growing applications in drug discovery. Significant trends for the forecast period include enhanced use in cancer research, its integration with multi-omics studies, adoption in drug discovery, the development of automated sequencing platforms, and an increase in clinical diagnostics applications.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12655&type=smp
Which Major Factors Are Driving The Expansion Of The Single-Cell Genome Sequencing Market?
The rising prevalence of cancer is projected to boost the single-cell genome sequencing market’s growth moving forward. Cancer refers to a broad spectrum of illnesses where abnormal cells develop and divide uncontrollably. It stems from alterations in the genes responsible for regulating cell division and maintaining normal cell function. Since cancer is characterized by genetic changes, single-cell genome sequencing can help uncover the genetic modifications present in individual cancer cells. For instance, in January 2023, the American Cancer Society, a US-based organization dedicated to fighting cancer, reported approximately 1.9 million new cancer cases and 609,360 cancer deaths in the US during 2022. Moreover, it is estimated that about 27.5 million new cancer cases and 16.3 million cancer deaths will occur by 2040. Therefore, the increasing incidence of cancer is anticipated to drive the expansion of the single-cell genome sequencing market.
How Is The Single-Cell Genome Sequencing Market Segmented Across Key Categories?
The single-cell genome sequencing market covered in this report is segmented –
1) By Type: Instruments, Reagents
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Quantitative Polymerase Chain Reaction (qPCR), Microarray, Multiple Displacement Amplification (MDA)
3) By Disease Area: Cancer, Immunology, Prenatal Diagnosis, Neurobiology, Microbiology, Other Disease Areas
4) By Application: Circulating Cells, Cell Differentiation Or Reprogramming, Genomic Variation, Subpopulation Characterization, Other Applications
5) By End User: Academic Research Laboratories, Biotechnology Biopharmaceutical Companies, Clinics, Other End Users
Subsegments:
1) By Instruments: Single-Cell Isolation Systems, Sequencing Platforms, Automation And Robotic Systems
2) By Reagents: Library Preparation Kits, Amplification Reagents, DNA Extraction Kits, Quality Control Reagents
What Trends Are Projected To Affect The Single-Cell Genome Sequencing Market?
Leading firms within the single-cell genome sequencing market are concentrating their efforts on advancing single cell proteomics. Single cell proteomics is an emerging field dedicated to understanding the diverse protein expression patterns observed in individual cells. This involves combining single-cell genomics with proteomics methods to investigate the connection between genomic data and protein expression at the individual cell scale. As an illustration, in October 2023, Proteome Sciences plc, a biotechnology company headquartered in the UK, introduced SysQuant SCP, a commercial service for single-cell proteomics that utilizes the strengths of its TMTproTM isobaric labelling reagents. The SysQuant SCP pipeline produces and examines quantitative mass spectrometry data to detect subtle differences not only within individual cells but also among subpopulations of the identical primary cell type. This information will greatly enhance our comprehension of the biological factors driving heterogeneity and evolution in disease and therapeutic response contexts, thereby offering novel therapeutic and diagnostic targets for personalized medicine.
Who Are The Dominant Players Shaping The Single-Cell Genome Sequencing Market Landscape?
Major companies operating in the single-cell genome sequencing market are F Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., DH Life Sciences LLC., Becton Dickinson And Company (BD), Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN GmbH, Bio-Techne Corporation, BGI Genomics Co. Ltd., Fulgent Genetics Inc., 10x Genomics Inc., Promega Corporation, Takara Bio Inc., Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc., Standard BioTools Inc., Singleron Biotechnologies, MGI Tech Co. Ltd, GENEWIZ Inc., Mission Bio Inc., Zymo Research Corporation, Menarini Silicon Biosystems SpA, Novogene Co. Ltd., RareCyte Inc., Fluxion Biosciences Inc., Single Cell Discoveries B.V., Parse Biosciences Inc., BioSpyder Technologies Inc., SeqWell Inc.
Read the full single-cell genome sequencing market report here:
https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report
Which Region Currently Holds The Largest Share Of The Single-Cell Genome Sequencing Market?
North America was the largest region in the single-cell genome sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell genome sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Single-Cell Genome Sequencing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12655&type=smp
Browse Through More Reports Similar to the Global Single-Cell Genome Sequencing Market 2026, By The Business Research Company
Single Cell Analysis Market
https://www.thebusinessresearchcompany.com/report/single-cell-analysis-market
Whole Genome And Exome Sequencing Global Market Report
Metagenomic Sequencing Global Market Report
https://www.thebusinessresearchcompany.com/report/metagenomic-sequencing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model